Article Information
PubMed
Print ISSN
Online ISSN
History
- Received June 9, 2011
- Accepted October 28, 2011
- Published online January 18, 2012.
Article Versions
- Earlier version (October 28, 2011 - 08:23).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- James C. Ermer,
- Mary B. Haffey,
- Walter J. Doll,
- Patrick Martin,
- Erik P. Sandefer,
- Kerry Dennis,
- Mary Corcoran,
- Laura Trespidi and
- Richard C. Page
- Clinical Pharmacology, Shire Development Inc., Wayne, Pennsylvania (J.C.E., M.B.H., P.M., K.D., M.C.); Scintipharma Inc., Lexington, Kentucky (W.J.D., E.P.S., R.C.P.); and Product Development, Shire Development Inc., Wayne, Pennsylvania (L.T.)
- Address correspondence to:
James Ermer, Shire Development Inc., Clinical Pharmacology and Pharmacokinetics, 725 Chesterbrook Blvd., Wayne, PA 19087. E-mail: jaermer{at}shire.com
This work was previously presented as follows: Ermer J, Haffey M, Doll W, Martin P, Sandefer E, Buckwalter M, Trespidi L, and Page R (2010) Pharmacokinetic profile & safety of lisdexamfetamine dimesylate after target gastrointestinal release or oral administration in healthy adults. U.S. Psychiatric and Mental Health Congress; 2010 Nov 18–21; Kissimmee, FL. Continuing Medical Education, LLC, Jersey City, NJ.